Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 11, 2009, Pages 1179-1187

  Ejskjaer, N ^b   Vestergaard, E T ^b   HellstrOm P M ^c   Gormsen, L C ^b   Madsbad, S ^d   Madsen, J L ^d   Jensen, T A ^e   Pezzullo, J C ^f   Christiansen, J S ^b   Shaughnessy, L ^a   Kosutic, G ^a  

^a Tranzyme Pharma   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

^d HVIDOVRE HOSPITAL   (Denmark)

^e Cyncron Clinical Research Unit   (Denmark)

^f GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL AGENT; GHRELIN; GLUCOSE; GROWTH HORMONE; HORMONE RECEPTOR STIMULATING AGENT; PLACEBO; SOMATOMEDIN C; TZP 101; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GROWTH HORMONE BLOOD LEVEL; HEART RATE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORTHOSTATIC HYPOTENSION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STOMACH EMPTYING; STOMACH PARESIS; TEST MEAL; VITAL SIGN; VOMITING;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES COMPLICATIONS; DOUBLE-BLIND METHOD; FEMALE; GASTRIC EMPTYING; GASTROPARESIS; GHRELIN; GLUCOSE CLAMP TECHNIQUE; HUMANS; MACROCYCLIC COMPOUNDS; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 66149083914     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.03986.x     Document Type: Article

References (30)

1. Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum R. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term followup of patients with gastroparesis. Dig Dis Sci 1998 43 : 2398 404. (Pubitemid 28531310)
2. Talley NJ, Young L, Bytzer P, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol 2001 96 : 71 6. (Pubitemid 32104810)
3. Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M. Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 2002 19 : 177 94. (Pubitemid 34429648)
4. Kuo P, Rayner CK, Jones KL, Horowitz M. Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists. Drugs 2007 67 : 1671 87. (Pubitemid 47263177)
5. Friedenberg FK, Parkman HP. Advances in the management of gastroparesis. Curr Treat Options Gastroenterol. 2007 10 : 283 93. (Pubitemid 47193512)
6. Abell TL, Bernstein RK, Cutts T, et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006 18 : 263 83.
7. Ejskjaer NT, Bradley JL, Buxton-Thomas MS, et al. Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 1999 16 : 488 95.
8. Guy RJ, Dawson JL, Garrett JR, et al. Diabetic gastroparesis from autonomic neuropathy: surgical considerations and changes in vagus nerve morphology. J Neurol Neurosurg Psychiatry 1984 47 : 686 91. (Pubitemid 14075411)
9. Watkins PJ, Buxton-Thomas MS, Howard ER. Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med 2003 20 : 58 63. (Pubitemid 36098866)
10. Jones MP, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 2003 98 : 2122 9. (Pubitemid 37305346)
11. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000 141 : 4255 61.
12. Fukuda H, Mizuta Y, Isomoto H, et al. Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol 2004 39 : 1209 14. (Pubitemid 39656835)
13. Murray CD, Martin NM, Patterson M, et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005 54 : 1693 8. (Pubitemid 41697666)
14. Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005 22 : 847 53. (Pubitemid 41568544)
15. Binn M, Albert C, Gougeon A, et al. Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides. 2006 27 : 1603 6. (Pubitemid 43866263)
16. Vestergaard ET, Hansen TK, Gormsen LC, et al. Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects. Am J Physiol Endocrinol Metab. 2007 292 : E1829 36. (Pubitemid 47084720)
17. Lasseter KC, Shaughnessy L, Cummings D, et al. Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study. J Clin Pharmacol 2008 48 : 193 202.
18. Venkova K, Fraser G, Hoveyda HR, Greenwood-Van Meerveld B. Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus. Dig Dis Sci 2007 52 : 2241 8. (Pubitemid 47246531)
19. Revicki DA, Rentz AM, Dubois D, et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 2004 13 : 833 44. (Pubitemid 38509983)
20. Feldman EL, Stevens MJ. Clinical testing in diabetic peripheral neuropathy. Can J Neurol Sci 1994 21 : S3 7. (Pubitemid 24359766)
21. Rosenfalck AM, Almdal T, Viggers L, Madsbad S, Hilsted J. A low-fat diet improves peripheral insulin sensitivity in patients with Type 1 diabetes. Diabet Med 2006 23 : 384 92.
22. Guo JP, Maurer AH, Fisher RS, Parkman HP. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci 2001 46 : 24 9. (Pubitemid 32221834)
23. Espelund U, Hansen TK, Hojlund K, et al. Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects. J Clin Endocrinol Metab 2005 90 : 741 6. (Pubitemid 40279189)
24. Tougas G, Chen Y, Coates G, et al. Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting. Am J Gastroenterol 2000 95 : 78 86. (Pubitemid 30041539)
25. Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000 95 : 1456 62. (Pubitemid 30396302)
26. Jones KL, Russo A, Stevens JE, Wishart JM, Berry MK, Horowitz M. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001 24 : 1264 9. (Pubitemid 33716409)
27. Stanghellini V, Tosetti C, Horowitz M, et al. Predictors of gastroparesis in out-patients with secondary and idiopathic upper gastrointestinal symptoms. Dig Liver Dis. 2003 35 : 389 96. (Pubitemid 41070452)
28. Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001 24 : 371 81. (Pubitemid 32119141)
29. Chey WY, Chang T. Neural hormonal regulation of exocrine pancreatic secretion. Pancreatology 2001 1 : 320 35. (Pubitemid 33758409)
30. Peeters TL. Central and peripheral mechanisms by which ghrelin regulates gut motility. J Physiol Pharmacol 2003 54 (Suppl 4 95 103.